IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $115,656 | -3.3% | 18,929 | +1.1% | 0.01% | -12.5% |
| Q4 2022 | $119,627 | -30.0% | 18,721 | +4.9% | 0.01% | -27.3% |
| Q3 2022 | $171,000 | -36.7% | 17,842 | +10.2% | 0.01% | -21.4% |
| Q1 2022 | $270,000 | +8.0% | 16,190 | +23.6% | 0.01% | -6.7% |
| Q4 2021 | $250,000 | -64.7% | 13,101 | -14.2% | 0.02% | -70.6% |
| Q4 2020 | $708,000 | +17.0% | 15,264 | -16.9% | 0.05% | +155.0% |
| Q3 2020 | $605,000 | – | 18,365 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |